IGC Pharma, Inc.IGCNYSE
Loading
Operating Income ContractionContracting
Percentile Rank43
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-7.45M
Near historical average
Percentile
P43
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-7.12M
Historical baseline
PeriodValueYoY Change
2025$-7.45M+24.0%
2024$-9.80M+15.3%
2023$-11.57M+25.0%
2022$-15.43M-76.8%
2021$-8.72M-27.1%
2020$-6.86M-47.8%
2019$-4.64M-159.5%
2018$-1.79M+12.9%
2017$-2.05M+29.3%
2016$-2.91M-